InnovateHealth Yale + Forge Translational

InnovateHealth Yale + Forge Translational sits under Yale Ventures as a health-focused grant route for Yale faculty and Yale spinouts. It is aimed at translational work in health, digital health, and medtech, and it belongs to the same family of internal accelerator funds that Yale uses to move university research toward commercialization. The program offers grants of about $50,000 to $250,000, with a median actual award of $100,000, on an annual cycle. It is restricted to Yale faculty-led teams and spinouts, and the available record points to an early-development window from TRL 2 to TRL 5. The support is grant-based, not equity, and the practical range is a fit for proof-of-concept work and early translational studies. Teams tend to benefit most when they can show a direct line from Yale research to a product or clinical use case, along with a credible plan for the next development step. The program is not open to nonprofits or individuals, so the real entry point is a Yale-backed venture team. Its positioning is straightforward: early health translation with enough technical definition to justify outside validation.

No upcoming rounds verified. Cadence: Annual.